OverviewJoin Spectradyne on Wednesday, May 29, 2024 at 1 pm Eastern Daylight Time (EDT) for an exciting live webinar featuring Dr. Mickey Pentecost, Founder and CEO of Diadem Biotherapeutics. Diadem is pioneering a revolutionary approach in immunotherapy by engineering extracellular vesicles (EVs) and lipid nanoparticles (LNPs) with surface-displayed multivalent protein ligands and oligonucleotides. Dr. Pentecost will discuss approaches for genetic and post-purification engineering of EVs and describe how Diadem leverages a diverse combination of methods to purify and characterize functionalized EVs, including Spectradyne’s Fluorescence Microfluidic Resistive Pulse Sensing (F-MRPS). This webinar will include a brief introduction to Spectradyne’s technology given by its CEO, Jean-Luc Fraikin, and conclude with an interactive live Q&A discussion with Dr. Pentecost. The Webinar is FREE -- Click Here to Register Now.
|
Agenda Topics- Engineering EVs and LNPs
- Extracellular Vesicles (EVs) and Lipid Nanoparticles (LNPs)
- Native vs. Engineered EVs and LNPs
- Therapeutics Development and Delivery using Engineered EVs and LNPs
|
|
Corporate Sponsors
|
Media Sponsors
|
|
Networking
|
|
|
|
|
|